524731 — Jenburkt Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹3.26bn
- IN₹2.70bn
- IN₹1.37bn
- 97
- 44
- 58
- 80
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 546 | 584 | 561 | 466 | 495 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 235 | 186 | 146 | 179 | 215 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 897 | 895 | 800 | 759 | 811 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 104 | 110 | 104 | 113 | 112 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,028 | 1,041 | 1,212 | 1,429 | 1,418 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 226 | 198 | 180 | 213 | 158 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 254 | 241 | 227 | 256 | 194 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 775 | 800 | 985 | 1,174 | 1,224 |
Total Liabilities & Shareholders' Equity | 1,028 | 1,041 | 1,212 | 1,429 | 1,418 |
Total Common Shares Outstanding |